Cargando…
MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
Melanoma is the utmost fatal kind of skin neoplasms. Molecular changes occurring during the pathogenic processes of initiation and progression of melanoma are diverse and include activating mutations in BRAF and NRAS genes, hyper-activation of PI3K/AKT pathway, inactivation of p53 and alterations in...
Autores principales: | Ghafouri-Fard, Soudeh, Gholipour, Mahdi, Taheri, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100681/ https://www.ncbi.nlm.nih.gov/pubmed/33968718 http://dx.doi.org/10.3389/fonc.2021.608987 |
Ejemplares similares
-
MicroRNA Signature in Renal Cell Carcinoma
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2020) -
Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021) -
MicroRNA profile in the squamous cell carcinoma: prognostic and diagnostic roles
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2020) -
The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
por: Samadian, Mohammad, et al.
Publicado: (2021) -
The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)